This announcement is a separate document:
アステラス製薬：ゾルベツキシマブ 欧州 CHMP が販売承認勧告を採択
Astellas Pharma: The European index CHMP has adopted a marketing authorization recommendation for Zolbetuximab.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.